COVID-19 Associated Mucormycosis: Scoping Review Protocol
View ORCID ProfileSalman Hussain, Harveen Baxi, View ORCID ProfileAbanoub Riad, Jitka Klugarová, Radim Líčeník, View ORCID ProfileMiloslav Klugar
doi: https://doi.org/10.1101/2021.05.30.21258068
Salman Hussain
1Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech EBHC: JBI Centre of Excellence, Masaryk University GRADE Centre), Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
Harveen Baxi
2Independent Researcher, New Delhi, India
Abanoub Riad
1Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech EBHC: JBI Centre of Excellence, Masaryk University GRADE Centre), Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
3Department of Public Health, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic
Jitka Klugarová
1Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech EBHC: JBI Centre of Excellence, Masaryk University GRADE Centre), Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
3Department of Public Health, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic
Radim Líčeník
1Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech EBHC: JBI Centre of Excellence, Masaryk University GRADE Centre), Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
Miloslav Klugar
1Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech EBHC: JBI Centre of Excellence, Masaryk University GRADE Centre), Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
3Department of Public Health, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic
Article usage
Posted June 01, 2021.
COVID-19 Associated Mucormycosis: Scoping Review Protocol
Salman Hussain, Harveen Baxi, Abanoub Riad, Jitka Klugarová, Radim Líčeník, Miloslav Klugar
medRxiv 2021.05.30.21258068; doi: https://doi.org/10.1101/2021.05.30.21258068
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (196)
- Cardiovascular Medicine (2876)
- Dermatology (245)
- Emergency Medicine (432)
- Epidemiology (12600)
- Forensic Medicine (10)
- Gastroenterology (810)
- Genetic and Genomic Medicine (4473)
- Geriatric Medicine (407)
- Health Economics (717)
- Health Informatics (2865)
- Health Policy (1057)
- Hematology (378)
- HIV/AIDS (907)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (465)
- Neurology (4231)
- Nursing (226)
- Nutrition (619)
- Oncology (2217)
- Ophthalmology (630)
- Orthopedics (255)
- Otolaryngology (322)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (489)
- Pediatrics (1182)
- Primary Care Research (485)
- Public and Global Health (6817)
- Radiology and Imaging (1501)
- Respiratory Medicine (906)
- Rheumatology (430)
- Sports Medicine (373)
- Surgery (475)
- Toxicology (59)
- Transplantation (204)
- Urology (175)